
EG1
CAS No. 693241-54-2
EG1 ( —— )
产品货号. M24706 CAS No. 693241-54-2
EG1 是 Pax2 转录激活的新型特异性抑制剂,靶向 DNA 结合域并抑制胚胎肾脏发育。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1199 | 有现货 |
![]() ![]() |
10MG | ¥1831 | 有现货 |
![]() ![]() |
25MG | ¥3686 | 有现货 |
![]() ![]() |
50MG | ¥5443 | 有现货 |
![]() ![]() |
100MG | ¥7671 | 有现货 |
![]() ![]() |
500MG | ¥15309 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称EG1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述EG1 是 Pax2 转录激活的新型特异性抑制剂,靶向 DNA 结合域并抑制胚胎肾脏发育。
-
产品描述EG1, a novel specific inhibitor of Pax2 transcription activation, targets the DNA binding domain and inhibits embryonic kidney development.
-
体外实验Cell Viability Assay Cell Line:Pax2 positive: a renal cell carcinoma line (RCC111), two ovarian carcinoma cell lines (TOV112D and ES-2); Pax2 negative: prostate cell lines 22Rv1, PC3 or the ovarian cancer cell line SK-OV-3 Concentration:0, 12.5, 25 μM Incubation Time:48 hours Result:All Pax2 positive cells exhibited a significant decrease in cell viability, whereas none of the Pax2 negative cells were affected.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Pax2
-
研究领域——
-
适应症——
化学信息
-
CAS Number693241-54-2
-
分子量390.39
-
分子式C22H18N2O5
-
纯度>98% (HPLC)
-
溶解度DMSO:70mg/ml(179.31mM; need ultrasonic)
-
SMILESCOc(cccc1)c1C(Nc(cc1)ccc1C(Nc(cccc1)c1C(O)=O)=O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Smith CB, Phillips T, Smith TJ. Using the New ASCO Clinical Practice Guideline for Palliative Care Concurrent With Oncology Care Using the TEAM Approach. Am Soc Clin Oncol Educ Book. 2017;37:714-723. doi: 10.14694/EDBK_175474. PubMed PMID: 28561696.
产品手册




关联产品
-
Isoarundinin II
Isoarundinin II is a natural product for research related to life sciences.
-
Xylan
木聚糖代表开花植物次生植物细胞壁中的主要半纤维素成分。
-
Phthalic acid
邻苯二甲酸是一种芳香族二羧酸。它是一种人类外源代谢物。